ibandronic acid

Poland

Drugs containing this active substance

  • IBANDRONATE POLPHARMA

    The medicine is used for the treatment of postmenopausal osteoporosis. It helps to inhibit bone loss, increase bone mass, and reduce the risk of vertebral fractures.

    Form: tablets, film-coated

    Active substance Dosage
    ibandronic acid 150 mg

    ATC: M05BA06

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used for the treatment of postmenopausal osteoporosis. It helps to inhibit bone loss, increase bone mass, and reduce the risk of bone fractures (especially vertebrae).

    Form: tablets, film-coated

    Active substance Dosage
    ibandronic acid 150 mg

    ATC: M05BA06

    Manufacturer: APL Swift Services (Malta) Ltd.

  • The medicine is used in adults with breast cancer that has spread to the bones, to prevent fractures and complications requiring surgery or radiation. It is also used when the cancer causes high calcium levels in the blood.

    Form: solution for infusion, concentrate

    Active substance Dosage
    ibandronic acid 6,414 mg

    ATC: M05BA06

    Manufacturer: Demo S.A.